belumosudil
General
Pronunciation:
bel-ue-moe-soo-dil
Trade Name(s)
- Rezurock
Ther. Class.
none assigned
Pharm. Class.
kinase inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Belumosudil." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Nursing Central, nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110961/11/belumosudil.
Vallerand AHA, Sanoski CAC. Belumosudil. Davis's Drug Guide. F.A. Davis Company; 2026. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110961/11/belumosudil. Accessed July 2, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Belumosudil. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110961/11/belumosudil
Vallerand AHA, Sanoski CAC. Belumosudil [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 July 02]. Available from: https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110961/11/belumosudil.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - belumosudil
ID - 110961
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Drug-Guide/110961/11/belumosudil
PB - F.A. Davis Company
ET - 20
DB - Nursing Central
DP - Unbound Medicine
ER -

Davis's Drug Guide

